• Adjunct in treatment of female infertility:
    • SC 0.25mg morning
    • Administered on day 5 or 6 of ovarian stimulation with gonadotrophin.
    • Continue through out until day of ovulation induction

Injection: 0.25mg

  • Injected in lower abdominal wall

Gonadotropin-releasing hormone (GnRH) antagonist

It antagonizes GnRH resulting in suppression of luteinizing hormone surge

  • Ovarian hyperstimulation syndrome
  • Injection site reaction
  • Elevated LFTs
  • Hypersensitivity to components
  • Pregnancy
  • Breastfeeding

None remarkable

                          Drug Status

Availability Prescription only
Pregnancy Category X
Breastfeeding Contraindicated
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Cetrotide 0.25mg Injection 1’s Merck Ltd Merck Ltd